Concluding Remarks: Systemic Treatment Considerations for Atopic Dermatitis in Patients of Childbearing Potential
Looking to the future of atopic dermatitis treatment, Drs Kiracofe and Murase offer concluding remarks on current unmet needs, the benefits of treatment guidelines, and the importance of treating itch in patients who are or may become pregnant.
Considerations for Breastfeeding, Lactation, and Postpartum in Family Planning Patients with Atopic Dermatitis
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, have a comprehensive discussion on treatment safety considerations for patients with atopic dermatitis who are breastfeeding.
Urgent Need for Consensus on Systemic Treatments for Atopic Dermatitis in Childbearing-Age Populations
Experts on atopic dermatitis weigh the risks and rewards of systemic treatments for pregnant patients and provide clinical insights on monitoring for adverse effects associated with dupilumab.
Managing Atopic Dermatitis Treatment Escalation in Pregnancy: Considerations and Approaches
Drs Kiracofe and Murase provide clinical insights on treatment escalation practices for patients with atopic dermatitis who are pregnant.
Informed Decisions: Dialogue with Treatment-Naïve Pregnant Patients Regarding Systemic Atopic Dermatitis Treatment Options
Focusing on pregnant patients with atopic dermatitis who are treatment naïve, Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, discuss best practices for informing patients on the available treatment options for this condition.
Insights on Transcription Binding in Atopic Dermatitis
Jenny Murase, MD, provides a brief overview of the Fc receptor and the role of transcription binding in atopic dermatitis.
Navigating Treatment Choices: Balancing Treatment Options for Childbearing-Age Patients
Dermatologists provide clinical insights on how they discuss atopic dermatitis treatment options, considerations, and safety concerns with patients who are pregnant or of childbearing age.
Exploring Changes in Atopic Dermatitis Severity Across the Pregnancy Journey
Jenny Murase, MD, describes how rising estrogen levels cause a shift in immune response from Th1 to Th2, causing potential atopic dermatitis exacerbations for patients who are pregnant.
Fostering Communication: Promoting Dialogue on Atopic Dermatitis Treatment Concerns in Patients of Childbearing Potential
Experts on atopic dermatitis discuss the importance of open dialogue with patients who are pregnant or of childbearing potential regarding the safety concerns associated with treatments for this condition.
Unveiling Treatment Gaps: Expert Perspectives on the Undermanagement of Patients with Atopic Dermatitis and Childbearing Potential
Dr. Elizabeth Kiracofe, MD, FAAD, and Dr. Jenny Murase, MD, introduce a discussion on the undertreatment of patients with atopic dermatitis, particularly focusing on pregnant individuals and those of childbearing age.
Navigating Delusional Infestations in Dermatology
Jenny Murase, MD, said the average dermatologist manages 2-3 patients with delusional infestations every 5 years. Learn what to expect and how to manage it with empathy.
Optimizing Vitiligo Care: Key Expert Takeaways
Dermatology Conferences and Meetings Calendar: April 2025
Daily Derm Times: March 31, 2025
Patients with Vitiligo Have a Lower Risk of Developing Serious Infections, New Poster Finds